The Lung Cancer Policy Network is pleased to see the UK National Screening Committee’s (UK NSC) recent announcement in favour of targeted lung cancer screening.
The UK NSC announced its decision on the recommendation for the introduction of the country’s first national cancer screening programme on 29 September 2022. The recommendation calls for the UK’s four nations (England, Scotland, Wales, Northern Ireland) to move towards implementation of targeted lung cancer screening, integrated with smoking cessation services, for people at high risk of the disease.
Professor David Baldwin, Lung Cancer Policy Network member and Honorary Professor of Medicine and Consultant Physician at the University of Nottingham (UK), responded to the new recommendations, saying:
In the UK recommendations, targeted screening for lung cancer is recommended for people aged 55 to 74. They also recognise the clear evidence from clinical trials showing that screening with low-dose computed tomography (LDCT) reduces lung cancer mortality.
Professor John Field, Lung Cancer Policy Network member and Professor of Molecular Oncology at the University of Liverpool, also responded, saying:
The Targeted Lung Heath Checks, a model that has been used with success in England, will provide an excellent starting point for implementation in the UK. The Targeted Lung Heath Checks use a wellness approach to lung health: participants are assessed for all lung conditions and offered LDCT scans if they meet the risk criteria, without specifically mentioning lung cancer in order to address any stigma surrounding the disease.
It is very encouraging to see another country recommending targeted LDCT screening. Our hope is that this decision will further encourage other countries to do so.
Network publishes year in review report to demonstrate annual achievements
The Lung Cancer Policy Network has published its 2023 in review: building the evidence base report, detailing what the Network and its members have achieved over the past year.
Meet our members: Ebba Hallersjö Hult
We speak to Ebba Hallersjö Hult, Co-founder and Head of Vision Zero Cancer, a mission-oriented innovation hub coordinated by Stockholm School of Economics Institute for Research, Sweden.
Lung cancer screening in Croatia: leading the way for earlier detection in Europe
We explore key considerations for the success of the lung cancer screening programme in Croatia, discussing the pivotal role that integrated technology and reimbursement for primary care providers have played.